NDC 58264-0118

D-112

Lachesis Muta Venom, Silicon Dioxide, Sodium Chloride, Ranunculus Bulbosus, Aconitum Napellus, Activated Charcoal, Nitroglycerin, Oyster Shell Calcium Carbonate, Crude, Anemone Pratensis, Plantago Major, Arsenic Trioxide, And Magnesium Phosphate, Dibasic Trihydrate

D-112 is a Sublingual Solution in the Human Otc Drug category. It is labeled and distributed by Dna Labs, Inc.. The primary component is Lachesis Muta Venom; Silicon Dioxide; Sodium Chloride; Ranunculus Bulbosus; Aconitum Napellus; Activated Charcoal; Nitroglycerin; Oyster Shell Calcium Carbonate, Crude; Anemone Pratensis; Plantago Major; Arsenic Trioxide; Magnesium Phosphate, Dibasic Trihydrate.

Product ID58264-0118_5a46b7c0-d8e3-47b3-9022-f61256c99965
NDC58264-0118
Product TypeHuman Otc Drug
Proprietary NameD-112
Generic NameLachesis Muta Venom, Silicon Dioxide, Sodium Chloride, Ranunculus Bulbosus, Aconitum Napellus, Activated Charcoal, Nitroglycerin, Oyster Shell Calcium Carbonate, Crude, Anemone Pratensis, Plantago Major, Arsenic Trioxide, And Magnesium Phosphate, Dibasic Trihydrate
Dosage FormSolution
Route of AdministrationSUBLINGUAL
Marketing Start Date1990-01-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDNA Labs, Inc.
Substance NameLACHESIS MUTA VENOM; SILICON DIOXIDE; SODIUM CHLORIDE; RANUNCULUS BULBOSUS; ACONITUM NAPELLUS; ACTIVATED CHARCOAL; NITROGLYCERIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; ANEMONE PRATENSIS; PLANTAGO MAJOR; ARSENIC TRIOXIDE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 58264-0118-1

29.57 mL in 1 BOTTLE, GLASS (58264-0118-1)
Marketing Start Date1990-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58264-0118-1 [58264011801]

D-112 SOLUTION
Marketing CategoryUNAPPROVED HOMEOPATHIC
Product TypeHUMAN OTC DRUG
Marketing Start Date1990-01-01
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.